Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Dydrogesterone Tablets

Approval Number

国药准字HJ20170221

CompanyAbbott Holdings B.V.

Registration Date

May 8, 2021

Previous Approval Numbers

H20170221

Drug Information

Generic Name

地屈孕酮片

Trade Name

达芙通

Dosage Form

片剂

Strength

10mg

Drug Type

化学药品

Registration Date

May 8, 2021

Expiry Date

May 7, 2026

Company Information

Applicant Company

Company NameAbbott Holdings B.V.

Company Address

Wegalaan 9, 2132 JD Hoofddorp, The Netherlands

Manufacturing Company

Company NameAbbott Biologicals B.V.

Company Address

Veerweg 12,8121 AA OLST, the Netherlands

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy